nach oben

Erschienen in:

02.07.2019 | Original Article

Neuronal damage and neuroinflammation markers in patients with autoimmune encephalitis and multiple sclerosis

verfasst von: V. Fominykh, L. Brylev, V. Gaskin, R. Luzin, A. Yakovlev, I. Komoltsev, I. Belousova, A. Rosliakova, A. Guekht, N. Gulyaeva

Erschienen in: Metabolic Brain Disease | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Inflammatory diseases of the central nervous system (CNS) are a diagnostic challenge to clinicians. Autoimmune encephalitis (AE) is an important diagnostic consideration in patients with CNS inflammatory disorders; despite of a wide range of neuropsychiatric symptoms it should be diagnosed as soon as possible and the patient transferred to the neurologist. We studied a group of AE patients (n = 24) as compared to multiple sclerosis (MS, n = 61) and control (n = 19) groups. Detailed clinical pictures of patients are presented. We focused on relevant cerebrospinal fluid (CSF) tests like protein levels, cytosis and oligoclonal bands, neuroinflammation indices (interleukin-6, soluble receptor of IL-6, neopterin, anti-ribosomal proteins antibodies) and markers of neurodegeneration (phosphorylated neurofilament heavy chain, pNfh). Elevated neopterin level was found in AE group as compared to the MS and control groups, while protein and pNfh were increased in both AE and MS groups. In the MS group, the cytosis and soluble receptor of IL-6 were higher as compared to the control group. Anti-ribosomal proteins antibodies were increased in a single patient with AE. High levels of protein were predictive of mortality in AE patients, while IL-6 and pNfh were elevated in severe AE patients. AE patients with paraneoplastic etiology demonstrated oligoclonal bands positivity. Taken together, our results suggest the neopterin as an additional marker of autoimmune brain inflammation. Though higher levels of protein, IL-6 and pNfh were found in patients with severe disease progression and death, prognostic values of these markers should be validated in larger cohorts of patients.

Nur mit Berechtigung zugänglich

Aguinis H, Gottfredson R, Joo H (2013)Best-practice recommendations for defining, identifying, and handling outliers. Organ Res Methods 16(2):270–301. https://doi.org/10.1177/1094428112470848 CrossRef

Andersson M, Alvarez-Cermeño J, Bernardi G et al (1994) Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 57(8):897–902 ReviewCrossRefPubMedPubMedCentral

Anesten B, Yilmaz A, Hagberg L, Zetterberg H, Nilsson S, Brew BJ, Fuchs D, Price RW, Gisslén M (2016) Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV. Neurol Neuroimmunol Neuroinflamm 3(6):e300. https://doi.org/10.1007/s13365-015-0371-x CrossRefPubMedPubMedCentral

Araki M, Matsuoka T, Miyamoto K, Kusunoki S, Okamoto T, Murata M et al (2014) Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitisoptica: a pilot study. Neurology 82(15):1302–1306. https://doi.org/10.1212/WNL.0000000000000317 CrossRefPubMedPubMedCentral

Azuar C, Levy R (2018) Behavioral disorders: the 'blind spot' of neurology and psychiatry. Rev Neurol (Paris) 174(4):182–189. https://doi.org/10.1016/j.neurol.2018.02.083 CrossRef

Baizabal-Carvallo JF, Jankovic J (2018) Autoimmune and paraneoplastic movement disorders: an update. J Neurol Sci 15(385):175–184. https://doi.org/10.1016/j.jns.2017.12.035 CrossRef

Briani C, Lucchetta M, Ghirardello A et al (2009) Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study. J Autoimmun 32(2):79–84. https://doi.org/10.1016/j.jaut.2008.12.002 CrossRefPubMed

Buchner C, Bryant C, Eslami A et al (2014)Anti-nuclear antibody screening using HEp-2 cells. J Vis Exp 23(88):e51211. https://doi.org/10.3791/51211 CrossRef

Byun J, Lee S, Moon J et al (2016) Distinct intrathecal interleukin-17/interleukin-6 activation in anti-N-methyl-d-aspartate receptor encephalitis. J Neuroimmunol 297:141–147CrossRefPubMed

Constantinescu R, Krýsl D, Andrén K, Asztély F, Bergquist F, Zetterberg H, Andreasson U, Axelsson M, Menachem EB, Jons D, Mahamud U, Malmeström C, Rosengren L, Blennow K (2017) Cerebrospinal fluid markers of neuronal and glial cell damage in patients with autoimmune neurologic syndromes with and without underlyingmalignancies. J Neuroimmunol 306:25–30. https://doi.org/10.1016/j.jneuroim.2017.02.018 CrossRefPubMed

Dale RC, Brilot F, Fagan E, Earl J (2009) Cerebrospinal fluid neopterin in pediatric neurology: a marker of active central nervous system inflammation. Dev Med Child Neurol 51(4):317–323. https://doi.org/10.1111/j.1469-8749.2008.03225.x CrossRefPubMed

Dalmau J (2015) Autoimmunity: the good, the bad, and the ugly. Neurol Neuroimmunol Neuroinflamm 2(6):e181. https://doi.org/10.1212/NXI.0000000000000181 CrossRefPubMedPubMedCentral

Dalmau J, Gleichman AJ, Hughes EG et al (2008)Anti-NMDA-receptor encephalitis: caseseries and analysis of the effects of antibodies. Lancet Neurol 7(12):1091–1098. https://doi.org/10.1016/S1474-4422(08)70224-2 CrossRefPubMedPubMedCentral

Deisenhammer F, Bartos A, Egg R et al (2006) EFNS Task Force. Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol 13(9):913–922. https://doi.org/10.1111/j.1468-1331.2006.01493.x CrossRefPubMed

Dubey D, Pittock SJ, Kelly CR et al (2018) Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol 83(1):166–177. https://doi.org/10.1002/ana.25131 CrossRefPubMedPubMedCentral

Edén A, Marcotte TD, Heaton RK et al (2016) Increased intrathecal immune activation in virally suppressed HIV-1 infected patients with neurocognitive impairment. PLoS One 11(6):e0157160. https://doi.org/10.1371/journal.pone.0157160 CrossRefPubMedPubMedCentral

Fominykh V, Frei E, Brylev L et al (2018a) Neurochem J 12:311. https://doi.org/10.1134/S1819712418040037 CrossRef

Fominykh V, Vorobyeva A, Onufriev MV et al (2018b) Interleukin-6, S-Nitrosothiols, and neurodegeneration in different central nervous system demyelinating disorders: is there a relationship? J Clin Neurol 14(3):327–332. https://doi.org/10.3988/jcn.2018.14.3.327 CrossRefPubMedPubMedCentral

Ganesh A, Wesley SF (2018) Practice current: when do you suspect autoimmuneencephalitis and what is the role of antibody testing? Neurol Clin Pract 8(1):67–73. https://doi.org/10.1212/CPJ.0000000000000423 CrossRefPubMedPubMedCentral

Gendron TF, C9ORF72 Neurofilament Study Group, Daughrity LM, Heckman MG, Diehl NN, Wuu J, Miller TM, Pastor P, Trojanowski JQ, Grossman M, Berry JD, Hu WT, Ratti A, Benatar M, Silani V, Glass JD, Floeter MK, Jeromin A, Boylan KB, Petrucelli L (2017) Phosphorylated neurofilament heavy chain: a biomarker of survivalfor C9ORF72-associated amyotrophic lateral sclerosis. Ann Neurol 82(1):139–146. https://doi.org/10.1002/ana.24980 CrossRefPubMedPubMedCentral

Graus F, Titulaer MJ, Balu R et al (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15(4):391–404. https://doi.org/10.1016/S1474-4422(15)00401-9 CrossRefPubMedPubMedCentral

Hagberg L, Cinque P, Gisslen M et al (2010) Cerebrospinal fluid neopterin: an informative biomarker of centralnervous system immune activation in HIV-1 infection. AIDS Res Ther 7:15. https://doi.org/10.1186/1742-6405-7-15 CrossRefPubMedPubMedCentral

Harutyunyan G, Hauer L, Dünser MW et al (2017) Autoimmune encephalitis at the NeurologicalIntensive care unit: etiologies, reasons for admission and survival. NeurocritCare 27(1):82–89. https://doi.org/10.1007/s12028-016-0370-7 CrossRef

Hébert J, Day GS, Steriade C et al (2018)Long-term CognitiveOutcomes in patients with autoimmune encephalitis. Can J Neurol Sci 25:1–5. https://doi.org/10.1017/cjn.2018.33 CrossRef

Herken J, Prüss H (2017) Red flags: clinical signs for identifying AutoimmuneEncephalitis in psychiatric patients. Front Psychiatry 8:25. https://doi.org/10.3389/fpsyt.2017.00025 CrossRefPubMedPubMedCentral

Honnorat J, Plazat LO (2018) Autoimmune encephalitis and psychiatric disorders. Rev Neurol (Paris) 174(4):228–236. https://doi.org/10.1016/j.neurol.2017.11.004 CrossRef

Horellou P, Wang M, Keo V et al (2015) Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis. J Neuroimmunol 289:1–7. https://doi.org/10.1016/j.jneuroim.2015.10.002 CrossRefPubMed

Hottenrott T, Dersch R, Berger B et al (2015) The intrathecal, polyspecific antiviral immune response in neurosarcoidosis, acute disseminated encephalomyelitis and autoimmune encephalitis compared tomultiple sclerosis in a tertiary hospital cohort. Fluids Barriers CNS 12:27. https://doi.org/10.1186/s12987-015-0024-8 CrossRefPubMedPubMedCentral

Körtvelyessy P, Prüss H, Thurner L et al (2018) Biomarkers of neurodegeneration in autoimmune-mediated encephalitis. FrontNeurol 9:668. https://doi.org/10.3389/fneur.2018.00668. eCollection 2018CrossRef

Kothur K, Wienholt L, Mohammad SS et al (2016) Utility of CSF cytokine/chemokines as markers of active intrathecal inflammation: comparison of demyelinating, anti-NMDAR and enteroviral encephalitis. PLoS One 11(8):e0161656. https://doi.org/10.1371/journal.pone.0161656 eCollection 2016CrossRefPubMedPubMedCentral

Lascano AM, Vargas MI, Lalive PH (2018) Diagnostic tools for immune causes of encephalitis. Clin Microbiol Infect. https://doi.org/10.1016/j.cmi.2018.12.012

Lee SK, Lee ST (2016) The laboratory diagnosis of autoimmune encephalitis. J Epilepsy Res 6(2):45–50. https://doi.org/10.14581/jer.16010 CrossRefPubMedPubMedCentral

Leypoldt F, Armangue T, Dalmau J (2015) Autoimmune encephalopathies. Ann N Y AcadSci 1338:94–114. https://doi.org/10.1111/nyas.12553 CrossRef

Li L, Sun L, Ret al D (2017) Application of the 2016 diagnostic approach for autoimmune encephalitis from lancet neurology to Chinese patients. BMC Neurol 17:195. https://doi.org/10.1186/s12883-017-0974-3 CrossRefPubMedPubMedCentral

Liao S, Qian Y, Hu H et al (2017) Clinical characteristics and predictors of outcome for Onconeural antibody-associated disorders: a retrospective analysis. Front Neurol 8:584. https://doi.org/10.3389/fneur.2017.00584 CrossRefPubMedPubMedCentral

Lin WL, Chi H, Huang FY et al (2016) Analysis of clinical outcomes inpediatric bacterial meningitis focusing on patients without cerebrospinal fluid pleocytosis. J Microbiol Immunol Infect 49(5):723–728. https://doi.org/10.1016/j.jmii.2014.08.013 CrossRefPubMed

Molero-Luis M, Fernandez-Urena S et al (2013) Cerebrospinal fluid neopterin analysis in neuropediatric patients: establishment of a new cut off-value for the identification of inflammatory-immune mediated processes. PLoS One 8(12):e83237. https://doi.org/10.1371/journal.pone.0083237 CrossRefPubMedPubMedCentral

Motta I, Allice T, Romito A et al (2017) Cerebrospinal fluid viral load and neopterin in HIV-positive patients with undetectable viraemia. Antivir Ther 22(6):539–543. https://doi.org/10.3851/IMP3140 CrossRefPubMed

Padberg F, Feneberg W, Schmidt S et al (1999) CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis. J Neuroimmunol 99(2):218–223. https://doi.org/10.1016/S0165-5728(99)00120-4 CrossRefPubMed

Pollak TA, Lennox BR (2018) Time for a change of practice: the real-world value of testing for neuronal autoantibodies in acute first-episode psychosis. BJ Psych Open 4(4):262–264. https://doi.org/10.1192/bjo.2018.27 CrossRef

Sarigecili E, Cobanogullari MD, Komur M et al (2018) Mult Scler Relat Disord 28:101–103. https://doi.org/10.1016/j.msard.2018.12.017 CrossRefPubMed

Stelmasiak Z, Kozioł-Montewka M, Dobosz B, Rejdak K (2001)IL-6 and sIL-6R concentration in the cerebrospinal fluid and serum of MS patients. Med SciMonit 7(5):914–918

Thompson AJ, Banwell BL, Barkhof F et al (2018a) Diagnosis of multiple sclerosis: 2017revisions of the McDonald criteria. Lancet Neurol 17(2):162–173. https://doi.org/10.1016/S1474-4422(17)30470-2 CrossRefPubMed

Thompson J, Bi M, Murchison AG, Makuch M et al (2018b) Faciobrachial dystonic seizures study group. The importance of early immunotherapy in patients with faciobrachial dystonic seizures. Brain 141(2):348–356. https://doi.org/10.1093/brain/awx323 CrossRefPubMed

Tkachenko OY, Lapin SV, Mazing AV et al (2017) The comparative analysis of immunologic techniques of detection of anti-phospholipid antibodies. Klin Lab Diagn 62(1):40–44 RussianPubMed

Varley J, Taylor J, Irani SR (2018)Autoantibody-mediated diseases of the CNS:structure, dysfunction and therapy. Neuropharmacology 132:71–82. https://doi.org/10.1016/j.neuropharm.2017.04.046 CrossRefPubMed

Vorobyeva AA, Fominykh VV, Onufriev MV et al (2014) Neurochem J 8:221. https://doi.org/10.1134/S1819712414030143 CrossRef

Wagner JN, Kalev O, Sonnberger M, Krehan I, von Oertzen T (2018) Evaluation of clinical and Paraclinical findings for the differential diagnosis of Autoimmuneand infectious encephalitis. Front Neurol 9:434. https://doi.org/10.3389/fneur.2018.00434 CrossRefPubMedPubMedCentral

Wilken M, Ameghino L, Cammarota Á, Nogués MA, Del Castillo M, Farez MF (2017) Clinical and cerebrospinal fluid findings contribute to the early differentiation betweeninfectious and noninfectious encephalitis. Medicina (B Aires) 77(3):214–221

Yasar KK, Pehlivanoglu F, Sengoz G (2010) Predictors of mortality in tuberculousmeningitis: a multivariate analysis of 160 cases. Int J Tuberc Lung Dis 14(10):1330–1335PubMed

Yeshokumar AK, Gordon-Lipkin E, Arenivas A, Cohen J, Venkatesan A, Saylor D, Probasco JC (2017) Neurobehavioral outcomes in autoimmune encephalitis. J Neuroimmunol 312:8–14. https://doi.org/10.1016/j.jneuroim.2017.08.010 CrossRefPubMed

Titel: Neuronal damage and neuroinflammation markers in patients with autoimmune encephalitis and multiple sclerosis
verfasst von: V. Fominykh
L. Brylev
V. Gaskin
R. Luzin
A. Yakovlev
I. Komoltsev
I. Belousova
A. Rosliakova
A. Guekht
N. Gulyaeva
Publikationsdatum: 02.07.2019
Verlag: Springer US
Erschienen in: Metabolic Brain Disease / Ausgabe 5/2019
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-019-00452-x

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

23.04.2024 | Demenz | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Neuronal damage and neuroinflammation markers in patients with autoimmune encephalitis and multiple sclerosis

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2019

Re-examining the role of ventral tegmental area dopaminergic neurons in motor activity and reinforcement by chemogenetic and optogenetic manipulation in mice

Laboratory diagnosis of the Niemann-Pick type C disease: an inherited neurodegenerative disorder of cholesterol metabolism

Type 2 diabetes induced oxidative brain injury involves altered cerebellar neuronal integrity and elemental distribution, and exacerbated Nrf2 expression: therapeutic potential of raffia palm (Raphia hookeri) wine

Exon 2 deletion represents a common mutation in Turkish patients with fructose-1,6-bisphosphatase deficiency

N6-(2-hydroxyethyl)-adenosine from Cordyceps cicadae attenuates hydrogen peroxide induced oxidative toxicity in PC12 cells

Time-dependent impairments in learning and memory in Streptozotocin-induced hyperglycemic rats

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie